Hesperetin Liposomes for Cancer Therapy

E-ISSN： 1875-5704|13|5|711-719

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.13, Iss.5, 2016-08, pp. : 711-719

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of ligand-targeted liposomes for cancer therapy

By Noble Charles O Kirpotin Dmitri B Hayes Mark E Mamot Christoph Hong Keelung Park John W Benz Christopher C Marks James D Drummond Daryl C

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. : 335-353

Informa Healthcare

Access to resources Recommend Favorite

Liposomes for photodynamic therapy

By Derycke A.S.L. de Witte P.A.M.

Advanced Drug Delivery Reviews, Vol. 56, Iss. 1, 2004-01 ,pp. : 17-30

Elsevier

Access to resources Recommend Favorite

Ligand-Targeted Liposomes for Cancer Treatment

Current Drug Delivery, Vol. 2, Iss. 4, 2005-10 ,pp. : 369-381

Bentham Science Publishers

Access to resources Recommend Favorite

Stimuli-responsive Smart Liposomes in Cancer Targeting

Current Drug Targets, Vol. 19, Iss. 3, 2018-02 ,pp. : 259-270

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Liposomes for siRNA Delivery to Cancer

Current Pharmaceutical Design, Vol. 24, Iss. 23, 2018-06 ,pp. : 2664-2672

Bentham Science Publishers

Access to resources Recommend Favorite